Treatment with a Urokinase Receptor-derived Cyclized Peptide Improves Experimental Colitis by Preventing Monocyte Recruitment and Macrophage Polarization
about
Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Relieve Inflammatory Bowel Disease in Mice.Short peptides interfering with signaling pathways as new therapeutic tools for cancer treatment.Human umbilical cord mesenchymal stem cells alleviate inflammatory bowel disease through the regulation of 15-LOX-1 in macrophages.
P2860
Treatment with a Urokinase Receptor-derived Cyclized Peptide Improves Experimental Colitis by Preventing Monocyte Recruitment and Macrophage Polarization
description
im Oktober 2016 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 October 2016
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2016
@uk
name
Treatment with a Urokinase Rec ...... nt and Macrophage Polarization
@en
Treatment with a Urokinase Rec ...... nt and Macrophage Polarization
@nl
type
label
Treatment with a Urokinase Rec ...... nt and Macrophage Polarization
@en
Treatment with a Urokinase Rec ...... nt and Macrophage Polarization
@nl
prefLabel
Treatment with a Urokinase Rec ...... nt and Macrophage Polarization
@en
Treatment with a Urokinase Rec ...... nt and Macrophage Polarization
@nl
P2093
P2860
P50
P1476
Treatment with a Urokinase Rec ...... nt and Macrophage Polarization
@en
P2093
Alberto Malesci
Ali M Yousif
Andrea Piontini
Francesco Merlino
Paolo Grieco
Philippe Fonteyne
Silvio Danese
P2860
P304
P356
10.1097/MIB.0000000000000896
P577
2016-10-01T00:00:00Z